These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11136652)

  • 1. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 3. The emergence of pharmacotherapies for cognitive function in Down syndrome.
    Capone GT
    Am J Med Genet A; 2010 Dec; 152A(12):3026-7. PubMed ID: 21108389
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 5. Down syndrome and Alzheimer disease: response to donepezil.
    Lott IT; Osann K; Doran E; Nelson L
    Arch Neurol; 2002 Jul; 59(7):1133-6. PubMed ID: 12117361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
    Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J
    J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil use in the treatment of dementia associated with Down syndrome.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic therapy for Down's syndrome.
    Kishnani PS; Sullivan JA; Walter BK; Spiridigliozzi GA; Doraiswamy PM; Krishnan KR
    Lancet; 1999 Mar; 353(9158):1064-5. PubMed ID: 10199357
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal movements with donepezil in Alzheimer disease.
    Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B
    Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352
    [No Abstract]   [Full Text] [Related]  

  • 11. Questions about donepezil.
    Elie LM; Cole MG
    CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.
    Lu CJ; Tune LE
    Am J Geriatr Psychiatry; 2003; 11(4):458-61. PubMed ID: 12837675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral complications associated with donepezil.
    Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
    Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series.
    Spiridigliozzi GA; Heller JH; Crissman BG; Sullivan-Saarela JA; Eells R; Dawson D; Li J; Kishnani PS
    Am J Med Genet A; 2007 Jul; 143A(13):1408-13. PubMed ID: 17542008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil in vascular dementia: a viewpoint by Sandra E. Black.
    Black SE
    Drugs Aging; 2003; 20(15):1138. PubMed ID: 14651438
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Many Alzheimer patients untreated].
    MMW Fortschr Med; 2002 Oct; 144(40):51. PubMed ID: 12449096
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil: a clinical review of current and emerging indications.
    Román GC; Rogers SJ
    Expert Opin Pharmacother; 2004 Jan; 5(1):161-80. PubMed ID: 14680445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.